Transform Drug Testing with the FDA Modernization Act

Transform Drug Testing with the FDA Modernization Act

Name of Bill: FDA Modernization Act 2.0

Bill Number: S.5002 

Humane CosmeticsScientists and drug sponsors must have access to the best available, human-predictive technology when developing effective medicines for patients. The FDA Modernization Act 2.0 (S.5002) will give them that opportunity by changing archaic language that has historically guided all new drug development to rely upon animal testing—even when superior, human-based testing methods exist.  

“The passage of my bill will avoid the needless suffering of countless animals, now that experimental drug testing can be done with modern non-animal alternatives that are more scientifically relevant,” said bill sponsor Senator Cory Booker. “This legislation brings us one step closer to eliminating the cruel practice of unnecessary animal testing.”

Calls to Action:

  1. Please contact your U.S. Representative and urge them to support this bill.
  2. Spread the word! Share this page with your social network.

 

Recipients

  • Your Representative

Contact

*Required fields
 

If you take action and have not already registered, you will receive periodic updates and communications from National Anti-Vivisection Society.

Message

Urging Support of S.5002, the FDA Modernization Act 2.0

Dear [Decision Maker],

I am writing as your constituent to ask you to support the FDA Modernization Act 2.0, S.5002, which recently passed the U.S. Senate.
You are likely familiar with this bill as Representative Buchanan's version easily passed the House earlier this year.

The FDA Modernization Act 2.0 will bring drug development into the 21st century by making it clear that manufacturers can use innovative human-based testing methods to test drug toxicity and efficacy. For 84 years drug developers have been guided to use draconian animal tests, despite mounting evidence that such tests are inaccurate predictors of human response.

To solve today's pressing health concerns, drug developers must have access to the best science available. Please support S.5002.

Thank you for your consideration.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]